BMS-747158-02: A novel PET myocardial perfusion imaging agent

Journal of Nuclear Cardiology

Volumn 14, Issue 6, 2007, Pages 789-798

  Yu, Ming ^a   Guaraldi, Mary T ^a   Mistry, Mahesh ^a   Kagan, Mikhail ^a   McDonald, Jennifer L ^a   Drew, Kenneth ^a   Radeke, Heike ^a   Azure, Michael ^a   Purohit, Ajay ^a   Casebier, David S ^a   Robinson, Simon P ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

BMS 747158 02; mitochondrial complex I; myocardial perfusion imaging; positron emission tomography

Indexed keywords

2 TERT BUTYL 4 CHLORO 5 [4 (2 FLUROETHOXYMETHYL)BENZYLOXY] 2H PYRIDAZIN 3 ONE F 18; BMS 747158 02; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; FLOW RATE; HEART LEFT VENTRICLE; HEART MUSCLE PERFUSION; ISOLATED HEART; LIVER; LUNG; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIMATE; PRIORITY JOURNAL; RABBIT; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CELLS, CULTURED; IMAGE ENHANCEMENT; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; PYRIDAZINES; RABBITS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 36048972598     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.07.008     Document Type: Article

References (22)

1. Ritchie J.L., Bateman T.M., Bonow R.O., Crawford M.H., Gibbons R.J., Hall R.J., et al. Guidelines for clinical use of cardiac radionuclide imaging. Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology. J Am Coll Cardiol 25 (1995) 521-547
2. Clark A.N., and Beller G.A. The present role of nuclear cardiology in clinical practice. Q J Nucl Med Mol Imaging 49 (2005) 43-58
3. Beller G.A., and Bergmann S.R. Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol 11 (2004) 71-86
4. Glover D.K., Ruiz M., Edwards N.C., Cunningham M., Simanis J.P., Smith W.H., et al. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 91 (1995) 813-820
5. Glover D.K., and Okada R.D. Myocardial kinetics of Tc-MIBI in canine myocardium after dipyridamole. Circulation 81 (1990) 628-637
6. Glover D.K., Ruiz M., Yang J.Y., Smith W.H., Watson D.D., and Beller G.A. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow. Circulation 96 (1997) 2332-2338
7. Garcia E.V., Eisner R.L., and Patterson R.E. What should we expect from cardiac PET?. J Nucl Med 34 (1993) 978-980
8. Bergmann S.R. Quantification of myocardial perfusion with positron emission tomography. In: Bergmann S.R., and Sobel B.E. (Eds). Positron emission tomography of the heart (1992), Futura, Mount Kisco (NY) 97-127
9. Marshall R.C., Powers-Risius P., Reutter B.W., Taylor S.E., VanBrocklin H.F., Huesman R.H., et al. Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med 42 (2001) 272-281
10. Marshall R.C., Powers-Risius P., Reutter B.W., O'Neil J.P., La Belle M., Huesman R.H., et al. Kinetic analysis of 18F-fluorodihydrorotenone as a deposited myocardial flow tracer: comparison to 201Tl. J Nucl Med 45 (2004) 1950-1959
11. Yalamanchili P., Wexler E., Hayes M., Yu M., Bozeke J., Kagan M., et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol 14 (2007) 782-788
12. Leppo J.A., and Meerdink D.J. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 65 (1989) 632-639
13. Sansoy V., Glover D.K., Watson D.D., Ruiz M., Smith W.H., Simanis J.P., et al. Comparison of thallium-201 resting redistribution with technetium-99m-sestamibi uptake and functional response to dobutamine for assessment of myocardial viability. Circulation 92 (1995) 994-1004
14. Beller G.A., Watson D.D., Ackell P., and Pohost G.M. Time course of thallium-201 redistribution after transient myocardial ischemia. Circulation 61 (1980) 791-797
15. Okada R.D., Glover D., Gaffney T., and Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77 (1988) 491-498
16. Barth E., Stammler G., Speiser B., and Schaper J. Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man. J Mol Cell Cardiol 24 (1992) 669-681
17. Corbett J.R., Kritzman J.N., and Ficaro E.P. Attenuation correction for single photon emission computed tomography myocardial perfusion imaging. Curr Cardiol Rep 6 (2004) 32-40
18. Schwaiger M., and Melin J. Cardiological applications of nuclear medicine. Lancet 354 (1999) 661-666
19. Dayanikli F., Grambow D., Muzik O., Mosca L., Rubenfire M., and Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 90 (1994) 808-817
20. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41 (2003) 1387-1393
21. Lin J.W., Sciacca R.R., Chou R.L., Laine A.F., and Bergmann S.R. Quantification of myocardial perfusion in human subjects using 82Rb and wavelet-based noise reduction. J Nucl Med 42 (2001) 201-208
22. Madar I., Ravert H.T., Du Y., Hilton J., Volokh L., Dannals R.F., et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 47 (2006) 1359-1366